Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;20(2):225-31.
doi: 10.3201/eid2002.130644.

Monitoring human babesiosis emergence through vector surveillance New England, USA

Monitoring human babesiosis emergence through vector surveillance New England, USA

Maria A Diuk-Wasser et al. Emerg Infect Dis. 2014 Feb.

Abstract

Human babesiosis is an emerging tick-borne disease caused by the intraerythrocytic protozoan Babesia microti. Its geographic distribution is more limited than that of Lyme disease, despite sharing the same tick vector and reservoir hosts. The geographic range of babesiosis is expanding, but knowledge of its range is incomplete and relies exclusively on reports of human cases. We evaluated the utility of tick-based surveillance for monitoring disease expansion by comparing the ratios of the 2 infections in humans and ticks in areas with varying B. microti endemicity. We found a close association between human disease and tick infection ratios in long-established babesiosis-endemic areas but a lower than expected incidence of human babesiosis on the basis of tick infection rates in new disease-endemic areas. This finding suggests that babesiosis at emerging sites is underreported. Vector-based surveillance can provide an early warning system for the emergence of human babesiosis.

Keywords: Babesia microti; Borrelia burgdorferi; Connecticut; Ixodes scapularis; Lyme disease; Massachusetts; New England; emergence; human babesiosis; incidence ratio; infection prevalence; parasites; piroplasm; tick-borne pathogens.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Borrelia burgdorferi and Babesia microti infection prevalence among humans and Ixodes scapularis ticks, eastern Connecticut (CT) and Nantucket, Massachusetts (MA). Shading indicates human babesiosis incidence in study towns by year in which the disease became endemic in the town (defined as the first year babesiosis cases were reported for 2 consecutive years). I. scapularis nymphal infection prevalence is shown for B. microti and B. burgdorferi in Lyme/Old Lyme in 2007 and for Nantucket and northeastern CT in 2010, represented as a pie chart for each sampled location. RI, Rhode Island.
Figure 2
Figure 2
Linear regression model of the human ratio (disease incidence rate ratio) and the tick ratio (tick infection prevalence ratio). The regression model includes state-reported case data from disease-endemic sites and case diagnoses from both medical practices. The human ratio derived from state-reported case data in the emerging area (northeastern Connecticut) is also displayed.

References

    1. Vannier E, Krause PJ. Human babesiosis. N Engl J Med. 2012;366:2397–407 . 10.1056/NEJMra1202018 - DOI - PubMed
    1. Conrad PA, Kjemtrup AM, Carreno RA, Thomford J, Wainwright K, Eberhard M, et al. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. Int J Parasitol. 2006;36:779–89 . 10.1016/j.ijpara.2006.03.008 - DOI - PubMed
    1. Herwaldt BL, Linden JV, Bosserman E, Young C, Olkowska D, Wilson M. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med. 2011;155:509–19 . 10.7326/0003-4819-155-8-201110180-00362 - DOI - PubMed
    1. US Food and Drug Administration. Biological product and HCT/P deviation reports: annual summary for fiscal year 2008. [cited 2009 Oct]. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProb...
    1. Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. 2008;46:370–6 . 10.1086/525852 - DOI - PubMed

Publication types

LinkOut - more resources